Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.49 USD -1.13% Market Closed
Market Cap: 37.6m USD
Have any thoughts about
Lantern Pharma Inc.?
Write Note

Lantern Pharma Inc.
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lantern Pharma Inc.
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Lantern Pharma Inc.
NASDAQ:LTRN
Retained Earnings
-$55.2m
CAGR 3-Years
-63%
CAGR 5-Years
-66%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$25.5B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-18%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$30.8B
CAGR 3-Years
22%
CAGR 5-Years
36%
CAGR 10-Years
71%

See Also

What is Lantern Pharma Inc.'s Retained Earnings?
Retained Earnings
-55.2m USD

Based on the financial report for Dec 31, 2023, Lantern Pharma Inc.'s Retained Earnings amounts to -55.2m USD.

What is Lantern Pharma Inc.'s Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-66%

Over the last year, the Retained Earnings growth was -41%. The average annual Retained Earnings growth rates for Lantern Pharma Inc. have been -63% over the past three years , -66% over the past five years .

Back to Top